Association between the HLA DQB1*0301 gene and human papillomavirus infection in high-grade cervical intraepithelial neoplasia

International Journal of Gynecological Pathology

Volumn 18, Issue 3, 1999, Pages 206-210

  Lie, A Kathrine ^a,d   Skarsvåg, Sølvi ^a   Haugen, Olav A ^a   Skjeldestad, Finn Egil ^b   Olsen, Anne O ^c   Skovlund, Eva ^e   Rønningen, Kjersti S ^c  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b SINTEF   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e NONE

Author keywords

CIN; DQB1*0301; HPV; Recurrent disease

Indexed keywords

HLA DQ ANTIGEN;

ARTICLE; CANCER GRADING; CANCER RISK; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CARCINOGENESIS; WART VIRUS;

EID: 0033015403     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199907000-00003     Document Type: Article

References (42)

1. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
2. Olsen AO, Gjoen K, Sauer T, et al. Human papillomavirus and cervical intraepithelial neoplasia grade II-III: a population-based case-control study. Int J Cancer 1995;61:312-5.
3. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64.
4. zur Hausen, H. Papillomavirus infections: a major cause of human cancers. Biochim Biophys Acta 1996;1288:F55-78.
5. IARC Working group on the Evaluation Carcinogenic Risks to Humans. Human papillomaviruses. Lyon. IARC. 1995:1-409.
6. Gjoen K, Sauer T, Olsen AO, Orstavik I. Correlation between polymerase chain reaction and cervical cytology for detection of human papillomavirus infection in women with and without dysplasia. APMIS 1997;105:71-5.
7. Hildesheim A, Schiffman MH, Gravitt PE, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994;169:235-40.
8. Lie AK, Isaksen CV, Skarsvåg S, Haugen OA. Human papillomavirus in high-grade cervical intraepithelial neoplasia detected by morphology and PCR. A cytohistologic correlation of 277 cases treated by laser conization. Cytopathology 1999;10:112-121.
9. Shamanin V, zur Hausen H, Lavergne D, et al. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst 1996;88:802-11.
10. Wright TC, Sun XW. Anogenital papillomavirus infection and neoplasia in immunodeficient women. Obstet Gynecol Clin North Am 1996;23:861-93.
11. Barr BB, Benton EC, McLaren K, et al. Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet 1989; 1:124-9.
12. Majewski S, Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol 1995;131:1312-8.
13. Heiland Å, Borresen AL, Kristensen G, Ronningen KS. DQA1 and DQB1 genes in patients with squamous cell carcinoma of the cervix: relationship to human papillomavirus infection and prognosis. Cancer Epidemiol Biomarkers Prev 1994;3:479-86.
14. Wank R, Schendel DJ, Thomssen C. HLA antigens and cervical carcinoma. Nature 1992;356:22-3.
15. Nawa A, Nishiyama Y, Kobayashi T, et al. Association of human leukocyte antigen-B1*03 with cervical cancer in Japanese women aged 35 years and younger. Cancer 1995;75:518-21.
16. Gregoire L, Lawrence WD, Kukuruga D, Eisenbrey AB, Lancaster WD. Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women. Int J Cancer 1994;57:504-7.
17. Sastre-Garau X, Loste MN, Vincent-Salomon A, et al. Decreased frequency of HLA-DAB1*13 alleles in French women with HPV-positive carcinoma of the cervix. Int J Cancer 1996;69:159-64.
18. Apple RJ, Erlich HA, Klitz W, Manos MM, Becker TM, Wheeler CM, HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet 1994;6:157-62.
19. Glew SS, Duggan Keen M, Ghosh AK, et al. Lack of association of HLA polymorphisms with human papillomavirus-related cervical cancer. Hum Immunol 1993;37:157-64.
20. Allen M, Kalantari M, Ylitalo N, et al. HLA DQ-DR haplotype and susceptibility to cervical carcinoma: indications of increased risk for development of cervical carcinoma in individuals infected with HPV 18. Tissue Antigens 1996;48:32-7.
21. Odunsi K, Terry G, Ho L, Bell J, Cuzick J, Ganesan TS. Susceptibility to human papillomavirus-associated cervical intraepithelial neoplasia is determined by specific HLA DR-DQ alleles. Int J Cancer 1996;67:595-602.
22. David AL, Taylor GM, Gokhale D, Aplin JD, Seif MW, Tindall VR. HLA-DQB1*03 and cervical intraepithelial neoplasia type III [Abstract]. Lancet 1992;340:52.
23. Mehal WZ, Lo YM, Herrington CS, et al. Role of human papillomavirus in determining the HLA associated risk of cervical carcinogenesis. J Clin Pathol 1994;47:1077-81.
24. Apple RJ, Becker TM, Wheeler CM, Erlich HA. Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma. J Natl Cancer Inst 1995;87:427-36.
25. Sanjeevi CB, Hjelmstrom P, Hallmans G, et al. Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women. Int J Cancer 1996;68:409-14.
26. Helland A, Olsen AO, Gjoen K, et al. An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with the HLA-DQA1*0102-DQB1*0602 haplotype: a population-based case-control study of Norwegian women. Int J Cancer 1998;76:19-24.
27. Lie AK, Skjeldestad FE, Hagen B, Johannessen E, Skarsvåg S, Haugen OA. Comparison of light microscopy, in situ hybridization and polymerase chain reaction for detection of human papillomavirus in histological tissue of cervical intraepithelial neoplasia. APMIS 1997;105:115-20.
28. Lie AK, Skarsvåg S, Skomedal H, Haugen OA, Holm R. Expression of p53, MDM2 and p21 proteins in high-grade cervical intraepithelial neoplasia and relationship to human papillomavirus infection. Int J Gynecol Pathol 1998;18:5-11.
29. Skjeldestad FE, Hagen B, Lie AK, Isaksen C. Residual and recurrent disease after laser conization for cervical intraepithelial neoplasia. Obstet Gynecol 1997;90:428-33.
30. Lie AK, Skjeldestad FE, Hagen B, Haugen OA. Occurrence of human papillomavirus infection in cervical intraepithelial neoplasia. A retrospective histopathological study of 317 cases treated by laser conization. APMIS 1995;103:693-8.
31. Gjoen K, Olsen AO, Magnus P, Grinde B, Sauer T, Ørstavik I. Prevalence of human papillomavirus in cervical scrapes, as analyzed by PCR, in a population-based sample of women with and without cervical dysplasia. APMIS 1996;104:68-74.
32. Marsh SGE. HLA class II region sequences, 1998. Tissue Antigens 1998;51:467-507.
33. Becker TM, Wheeler CM, McGough NS, et al. Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women. J Am Med Assoc 1994;271:1181-8.
34. Bosch FX, Munoz N, de-Sanjose S, et al. Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993;2:415-22.
35. Davies DH, Strauss HJ. The significance of human leukocyte antigen associations with cervical cancer. Papillomavirus Report 1997;8:43-50.
36. Helland Å, Borresen AL, Kærn J, Ronningen KS, Thorsby E. HLA antigens and cervical carcinoma [Abstract]. Nature 1992;356:23.
37. Wank R, Thomssen C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature 1991;352:723-5.
38. Wright TC, Ferenczy A, Kurman RJ. Precancerous lesions of the cervix. In: Kurman RJ ed. Blaustein's pathology of the female genital tract, 4th ed. New York, NY: Springer Verlag. 1994;229-78.
39. Ismail SM, Colclough AB, Dinnen JS, et al. Observer variation in histopathological diagnosis and grading of cervical intraepithelial neoplasia. Br Med J 1989;298:707-10.
40. Robertson AJ, Anderson JM, Beck JS, et al. Observer variability in histopathological reporting of cervical biopsy specimens. J Clin Pathol 1989;42:231-8.
41. Östör AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993;12:186-92.
42. Han R, Breitburd F, Marche PN, Orth G. Linkage of regression and malignant conversion of rabbit viral papillomas to MHC class II genes. Nature 1992;356:66-8.